Academic Journal
Q2Oncotarget
About Oncotarget
Oncotarget is a scholarly journal published by Impact Journals LLC. SCImago 2025 places it in Q2 with an SJR of 0.828 and an H-index of 201.
Its listed coverage is 2010-2026 and its research categories include Oncology (Q2). The 2025 dataset reports 73 documents and 765 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Cancer-related molecular mechanisms research, MicroRNA in disease regulation, RNA modifications and cancer, Epigenetics and DNA Methylation, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism.
Recent Research Articles
Latest publications matched automatically by ISSN.
Re-expression of MHC-I to treat CNS cancers
Arseniy E. Yuzhalin
2026-09-08 · DOI: 10.18632/oncotarget.28917Emerging biomedical imaging applications of tumor-derived extracellular vesicles for premetastatic niche detection: Biological rationale, engineering strategies, and translational challenges
Omkar Dhaygude, Yun Chen, Yamauchi Suguru, Malcom Brock et al.
2026-08-28 · DOI: 10.18632/oncotarget.28916Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine
Kelly Crane, K. R. Seetharam Bhat, P. Grivas, Andrea Necchi et al.
2026-08-19 · DOI: 10.18632/oncotarget.28912Systematic methodological flaws in DNA contamination assessment of mRNA vaccines: A critical analysis of Achs et al. (2025)
Kevin McKernan, David J. Speicher, Jessica Rose
2026-08-14 · DOI: 10.18632/oncotarget.28913Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers
Bruna Almeida dos Santos, Natália Hogetop Freire, Livia Fratini, Matheus Dalmolin et al.
2026-08-07 · DOI: 10.18632/oncotarget.28911WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers
Wafik S. El-Deiry, Alberto Hernando-Calvo, Don Dizon, Shai Magidi et al.
2026-07-21 · DOI: 10.18632/oncotarget.28899Renal oncocytoma: Α case report and literature review
Areti Kalfoutzou, Cleopatra Rapti, Vasiliki Lagopulou, Eleftheria Bagiokou et al.
2026-07-02 · DOI: 10.18632/oncotarget.28893TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer
Nuzhat Khursheed, Syed Ishfa Andrabi, Natasha Thakur, Quratul Qadir et al.
2026-06-09 · DOI: 10.18632/oncotarget.28891DHHC3 interferes with antitumor immunity in melanoma cells
Chandan Sharma, Soonyean Hwang, Qingshi Liu, Martin E. Hemler et al.
2026-06-08 · DOI: 10.18632/oncotarget.28880A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Emily Bivens, Omar Atiq, Teresa Evans, Milan Bimali et al.
2026-06-05 · DOI: 10.18632/oncotarget.28892The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation
Kweku Ofosu-Asante, Jassy Mary S. Lazarte, Amarender Goud Burra, Nazarius S. Lamango et al.
2026-06-03 · DOI: 10.18632/oncotarget.28879Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer
Haylee Duval, Barbara Toomey, Michelle Karam, Tatum Braun et al.
2026-05-20 · DOI: 10.18632/oncotarget.28878Small bowel GIST harboring concurrent KIT exon 9 duplication and SDHC mutation: A case report
Cameron B. Speyer, Kyle D. Klingbeil, Manando Nakasaki, Sarah M. Dry et al.
2026-05-04 · DOI: 10.18632/oncotarget.28863Laryngeal leiomyosarcoma: A rare case report and literature review
Bolat Shalabaev, Svetlana Kurash, Aibar Nurzhanov, Dulat Serikbaiuly et al.
2026-05-04 · DOI: 10.18632/oncotarget.28862Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023
Navkirat Kahlon, Nahush Bansal, Sujatha Baddam, Jaisingh Rajput et al.
2026-04-28 · DOI: 10.18632/oncotarget.28877Oncotarget: Past, Present and Future: Trends in the publishing industry
Scientific Integrity Office at Oncotarget
2026-04-08 · DOI: 10.18632/oncotarget.28852Efficacy and safety of PD-1/ PD-L1 inhibitors as adjuvants in the treatment of patients with solid cancers: A systematic review and meta-analysis of randomized controlled trials
Maryam Aleid, Fatimah Aleid, Daniah Allbdi, Ahmad Rchdeih et al.
2026-03-31 · DOI: 10.18632/oncotarget.28855Cancer without borders: Policy frameworks for oncology care in humanitarian and conflict settings
Pragnesh Parmar, Gunvanti Rathod
2026-03-31 · DOI: 10.18632/oncotarget.28856Bibliometric mapping of glioma classification research through main path, key route, and K-core analyses
Kayode Ahmed, Juan E. Núñez-Ríos
2026-03-31 · DOI: 10.18632/oncotarget.28851Reviews
Community Reviews
Version History
September 8, 2026 at 12:04 am
September 8, 2026